Claire Poll, General Counsel at Verona Pharma plc (VRNA), sold 770,416 shares at $2.69 ($646K) on 2022-12-22, disclosed to the SEC on 2022-12-27.
Open-market sale of $646k VRNA by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 90,104 | $0 | 0.0% |
| 2 | $0.00 | 90,104 | $0 | 0.0% |
| 3 | $0.00 | 90,104 | $0 | 0.0% |
| 4 | $0.00 | 90,104 | $0 | 0.0% |
| 5 | $0.00 | 170,000 | $0 | 0.0% |
| 6 | $2.69 | 240,000 |
| $646K |
| 100.0% |
| Total | $0.84 avg | 770,416 | $646K | 100% |
| Filing → |
| VRNA | SELL | 2023-05-03 | $415K | — | Filing → |
| VRNA | SELL | 2023-02-03 | $394K | — | Filing → |